BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green MV, Raybuck JD, Zhang X, Wu MM, Thayer SA. Scaling Synapses in the Presence of HIV. Neurochem Res 2019;44:234-46. [PMID: 29541929 DOI: 10.1007/s11064-018-2502-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Watson Z, Tang SJ. Aberrant Synaptic Pruning in CNS Diseases: A Critical Player in HIV-Associated Neurological Dysfunction? Cells 2022;11:1943. [PMID: 35741071 DOI: 10.3390/cells11121943] [Reference Citation Analysis]
2 Wang L, Zeng Y, Zhou Y, Yu J, Liang M, Qin L, Zhou Y. Win55,212-2 Improves Neural Injury induced by HIV-1 Glycoprotein 120 in Rats by Exciting CB2R. Brain Research Bulletin 2022. [DOI: 10.1016/j.brainresbull.2022.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu D, Liu J, Xu T, Qiao H, Qi Y, Gao Y, Ailixire, Gao L, Li C, Xia M, Li H. Longitudinal trajectories of brain volume in combined antiretroviral therapy treated and untreated simian immunodeficiency virus-infected rhesus macaques. AIDS 2021;35:2433-43. [PMID: 34870927 DOI: 10.1097/QAD.0000000000003055] [Reference Citation Analysis]
4 Marks WD, Paris JJ, Barbour AJ, Moon J, Carpenter VJ, McLane VD, Lark ARS, Nass SR, Zhang J, Yarotskyy V, McQuiston AR, Knapp PE, Hauser KF. HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure. eNeuro 2021;8:ENEURO. [PMID: 33782102 DOI: 10.1523/ENEURO.0547-20.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Denton AR, Mactutus CF, Lateef AU, Harrod SB, Booze RM. Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage. J Neurovirol 2021;27:403-21. [PMID: 34003469 DOI: 10.1007/s13365-021-00960-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hermes DJ, Yadav-Samudrala BJ, Xu C, Paniccia JE, Meeker RB, Armstrong ML, Reisdorph N, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Lysle DT, Fitting S. GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration. Exp Neurol 2021;341:113699. [PMID: 33736974 DOI: 10.1016/j.expneurol.2021.113699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Irollo E, Luchetta J, Ho C, Nash B, Meucci O. Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders. Cell Mol Life Sci 2021;78:4283-303. [PMID: 33585975 DOI: 10.1007/s00018-021-03785-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Xiang Y, Xin J, Le W, Yang Y. Neurogranin: A Potential Biomarker of Neurological and Mental Diseases. Front Aging Neurosci 2020;12:584743. [PMID: 33132903 DOI: 10.3389/fnagi.2020.584743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wu MM, Thayer SA. HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses. eNeuro 2020;7:ENEURO. [PMID: 32471847 DOI: 10.1523/ENEURO.0119-20.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Mele AR, Marino J, Dampier W, Wigdahl B, Nonnemacher MR. HIV-1 Tat Length: Comparative and Functional Considerations. Front Microbiol 2020;11:444. [PMID: 32265877 DOI: 10.3389/fmicb.2020.00444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wu MM, Zhang X, Asher MJ, Thayer SA. Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder. Brain Res 2019;1724:146467. [PMID: 31539547 DOI: 10.1016/j.brainres.2019.146467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jacobs IR, Xu C, Hermes DJ, League AF, Xu C, Nath B, Jiang W, Niphakis MJ, Cravatt BF, Mackie K, Mukhopadhyay S, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Inhibitory Control Deficits Associated with Upregulation of CB1R in the HIV-1 Tat Transgenic Mouse Model of Hand. J Neuroimmune Pharmacol 2019;14:661-78. [PMID: 31372820 DOI: 10.1007/s11481-019-09867-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
13 Smith LK, Kuhn TB, Chen J, Bamburg JR. HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity. Curr HIV Res 2018;16:258-69. [PMID: 30280668 DOI: 10.2174/1570162X16666181003144740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
14 Putatunda R, Ho WZ, Hu W. HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence. AIDS Rev 2019;21:11-22. [PMID: 30899112 DOI: 10.24875/AIDSRev.19000003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Green MV, Thayer SA. HIV gp120 upregulates tonic inhibition through α5-containing GABAARs. Neuropharmacology 2019;149:161-8. [PMID: 30797029 DOI: 10.1016/j.neuropharm.2019.02.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang X, Green MV, Thayer SA. HIV gp120-induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK. J Neurochem 2019;148:499-515. [PMID: 30520043 DOI: 10.1111/jnc.14640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]